Bruker Co. (NASDAQ:BRKR) Sees Large Drop in Short Interest

Bruker Co. (NASDAQ:BRKRGet Rating) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 2,980,000 shares, a decrease of 18.6% from the April 30th total of 3,660,000 shares. Based on an average daily trading volume, of 819,900 shares, the short-interest ratio is currently 3.6 days. Approximately 2.9% of the company’s shares are sold short.

A number of equities analysts recently issued reports on the stock. Zacks Investment Research downgraded shares of Bruker from a “buy” rating to a “hold” rating and set a $64.00 price target for the company. in a research note on Tuesday, April 19th. StockNews.com assumed coverage on shares of Bruker in a research note on Thursday, March 31st. They issued a “buy” rating for the company. The Goldman Sachs Group decreased their price target on shares of Bruker from $73.00 to $60.00 and set a “sell” rating for the company in a research note on Wednesday, April 13th. Finally, SVB Leerink increased their price target on shares of Bruker from $84.00 to $85.00 and gave the stock an “outperform” rating in a research note on Monday, February 14th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, Bruker currently has an average rating of “Hold” and a consensus target price of $76.50.

Shares of NASDAQ BRKR opened at $64.19 on Tuesday. Bruker has a fifty-two week low of $55.80 and a fifty-two week high of $92.35. The company has a 50 day simple moving average of $61.70 and a two-hundred day simple moving average of $69.30. The company has a market capitalization of $9.58 billion, a price-to-earnings ratio of 34.51, a P/E/G ratio of 1.48 and a beta of 1.26. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.72 and a current ratio of 2.56.

Bruker (NASDAQ:BRKRGet Rating) last announced its earnings results on Wednesday, May 4th. The medical research company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.08. Bruker had a net margin of 11.47% and a return on equity of 31.16%. The business had revenue of $595.00 million during the quarter, compared to the consensus estimate of $572.50 million. During the same quarter last year, the firm earned $0.44 earnings per share. The business’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, analysts forecast that Bruker will post 2.31 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, June 17th. Investors of record on Wednesday, June 1st will be given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.31%. The ex-dividend date is Tuesday, May 31st. Bruker’s dividend payout ratio (DPR) is currently 10.75%.

Several institutional investors and hedge funds have recently made changes to their positions in BRKR. Zions Bancorporation N.A. bought a new stake in shares of Bruker during the first quarter valued at approximately $26,000. National Bank of Canada FI bought a new stake in shares of Bruker during the fourth quarter valued at approximately $27,000. Whittier Trust Co. bought a new stake in shares of Bruker during the fourth quarter valued at approximately $36,000. Meeder Asset Management Inc. purchased a new stake in Bruker in the first quarter worth approximately $41,000. Finally, Covestor Ltd purchased a new stake in Bruker in the fourth quarter worth approximately $42,000. 76.09% of the stock is owned by institutional investors.

About Bruker (Get Rating)

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.

See Also

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.